UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3375-3383

2009

Volltextzugriff (PDF)

Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2814-2818

2010

Volltextzugriff (PDF)

Efficacy of telavancin, a lipoglycopeptide antibiotic, in experimental models of Gram-positive infection

Expert review of anti-infective therapy, 2014-12, Vol.12 (12), p.1463-1475

2014

Volltextzugriff (PDF)

3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity

Bioorganic & medicinal chemistry letters, 2005-03, Vol.15 (5), p.1529-1534

2005

Volltextzugriff (PDF)

Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model

Bioorganic & medicinal chemistry letters, 2006-04, Vol.16 (7), p.2037-2041

2006

Volltextzugriff (PDF)

Quinolones as HCV NS5B polymerase inhibitors

Bioorganic & medicinal chemistry letters, 2011-01, Vol.21 (1), p.82-87

2011

Volltextzugriff (PDF)

Keto-1,3,4-oxadiazoles as cathepsin K inhibitors

Bioorganic & medicinal chemistry letters, 2006-06, Vol.16 (11), p.2909-2914

2006

Volltextzugriff (PDF)

Optimization of Subsite Binding to the β5 Subunit of the Human 20S Proteasome Using Vinyl Sulfones and 2-Keto-1,3,4-oxadiazoles: Syntheses and Cellular Properties of Potent, Selective Proteasome Inhibitors

Journal of medicinal chemistry, 2006-05, Vol.49 (10), p.2953-2968

2006

Volltextzugriff (PDF)

3-Heterocyclyl quinolone inhibitors of the HCV NS5B polymerase

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (1), p.300-304

2012

Volltextzugriff (PDF)

Synthesis of a statistically exhaustive fluorescent peptide substrate library for profiling protease specificity

Bioorganic & medicinal chemistry letters, 2000-12, Vol.10 (23), p.2639-2642

2000

Volltextzugriff (PDF)

Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers

Journal of thrombosis and thrombolysis, 2014, Vol.38 (2), p.235-240

2014

Volltextzugriff (PDF)

Peptide Ketobenzoxazole Inhibitors Bound to Cathepsin K

Biochemistry (Easton), 2003-12, Vol.42 (51), p.15018-15028

2003

Volltextzugriff (PDF)

Dissecting and Designing Inhibitor Selectivity Determinants at the S1 Site Using an Artificial Ala190 Protease (Ala190 uPA)

Journal of molecular biology, 2004-11, Vol.344 (2), p.527-547

2004

Volltextzugriff (PDF)

Structure-Guided Design of Peptide-Based Tryptase Inhibitors

Biochemistry (Easton), 2006-05, Vol.45 (19), p.5964-5973

2006

Volltextzugriff (PDF)

Expression and characterization of recombinant γ-tryptase

Protein expression and purification, 2006-09, Vol.49 (1), p.47-54

2006

Volltextzugriff (PDF)

The ITK Inhibitor Cpi-818 Blocks Activation of T Cells from Autoimmune Lymphoproliferative Syndrome (ALPS) Patients and Is Active in a Murine Model of ALPS

Blood, 2020-11, Vol.136 (Supplement 1), p.36-37

2020

Volltextzugriff (PDF)

Structure-activity relationship studies of a bisbenzimidazole-based, Zn2+-dependent inhibitor of HCV NS3 serine protease

Bioorganic & medicinal chemistry letters, 2001-09, Vol.11 (17), p.2355-2359

2001

Volltextzugriff (PDF)

Practical Robust Fit of Enzyme Inhibition Data

Methods in Enzymology, 2004, Vol.383, p.366-381

2004

Volltextzugriff (PDF)

High-Throughput Screening of Enzyme Inhibitors: Simultaneous Determination of Tight-Binding Inhibition Constants and Enzyme Concentration

Analytical biochemistry, 2000-11, Vol.286 (1), p.45-50

2000

Volltextzugriff (PDF)

Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-directed Serine Protease Inhibitors

Journal of molecular biology, 2003-05, Vol.329 (1), p.93-120

2003

Volltextzugriff (PDF)

Factor VIIa inhibitors: Gaining selectivity within the trypsin family

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (6), p.1596-1600

2006

Volltextzugriff (PDF)

Highly Selective Irreversible ITK Inhibitor Cpi-818 Reduces Acute Graft-Versus Host Disease

Blood, 2021-11, Vol.138 (Supplement 1), p.3814-3814

2021

Volltextzugriff (PDF)

Interleukin-2-Inducible T-Cell Kinase (ITK) Inhibitors for the Treatment of T-Cell Lymphoproliferative Disorders

Blood, 2018-11, Vol.132 (Supplement 1), p.4172-4172

2018

Volltextzugriff (PDF)

Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease

Bioorganic & medicinal chemistry letters, 2002-11, Vol.12 (21), p.3129-3133

2002

Volltextzugriff (PDF)

Design of novel, potent, and selective human β-tryptase inhibitors based on α-keto-[1,2,4]-oxadiazoles

Bioorganic & medicinal chemistry letters, 2006-08, Vol.16 (15), p.4036-4040

2006

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(58)

Sprache

Englisch
(58)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(33)
Biological And Medical Sciences
(23)
Medical Sciences
(19)
Pharmacology & Pharmacy
(19)
Pharmacology. Drug Treatments
(19)
Structure-Activity Relationship
(18)
Humans
(17)
Physical Sciences
(17)
Chemistry
(16)
Chemistry, Medicinal
(15)
Kinetics
(15)
Biochemistry & Molecular Biology
(14)
Chemistry, Organic
(14)
Animals
(10)
Crystallography, X-Ray
(10)
Models, Molecular
(9)
Drug Design
(8)
Molecular Structure
(8)
Serine Proteinase Inhibitors - Pharmacology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin

Efficacy of telavancin, a lipoglycopeptide antibiotic, in experimental models of Gram-positive infection

3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity

Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model

Quinolones as HCV NS5B polymerase inhibitors

Keto-1,3,4-oxadiazoles as cathepsin K inhibitors

Optimization of Subsite Binding to the β5 Subunit of the Human 20S Proteasome Using Vinyl Sulfones and 2-Keto-1,3,4-oxadiazoles: Syntheses and Cellular Properties of Potent, Selective Proteasome Inhibitors

3-Heterocyclyl quinolone inhibitors of the HCV NS5B polymerase

Synthesis of a statistically exhaustive fluorescent peptide substrate library for profiling protease specificity

Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers

Peptide Ketobenzoxazole Inhibitors Bound to Cathepsin K

Dissecting and Designing Inhibitor Selectivity Determinants at the S1 Site Using an Artificial Ala190 Protease (Ala190 uPA)

Structure-Guided Design of Peptide-Based Tryptase Inhibitors

Expression and characterization of recombinant γ-tryptase

The ITK Inhibitor Cpi-818 Blocks Activation of T Cells from Autoimmune Lymphoproliferative Syndrome (ALPS) Patients and Is Active in a Murine Model of ALPS

Structure-activity relationship studies of a bisbenzimidazole-based, Zn2+-dependent inhibitor of HCV NS3 serine protease

Practical Robust Fit of Enzyme Inhibition Data

High-Throughput Screening of Enzyme Inhibitors: Simultaneous Determination of Tight-Binding Inhibition Constants and Enzyme Concentration

Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-directed Serine Protease Inhibitors

Factor VIIa inhibitors: Gaining selectivity within the trypsin family

Highly Selective Irreversible ITK Inhibitor Cpi-818 Reduces Acute Graft-Versus Host Disease

Interleukin-2-Inducible T-Cell Kinase (ITK) Inhibitors for the Treatment of T-Cell Lymphoproliferative Disorders

Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease

Design of novel, potent, and selective human β-tryptase inhibitors based on α-keto-[1,2,4]-oxadiazoles

Suchergebnisse filtern